Researchers at the University of East Anglia (UEA) have revealed how the antibiotic-resistant superbug Acinetobacter baumannii evolved resistance in waves, peaking around 2005. This study, published on July 1, 2026, sheds light on the genetic history of this notorious pathogen that has quietly spread through hospitals for decades.
Understanding the Evolution of Acinetobacter baumannii
Using decades-old hospital samples, the UEA team, in collaboration with researchers from the Quadram Institute, Canada, and Mexico, pieced together the genetic evolution of A. baumannii, a pathogen known for its resilience against treatment. Lead researcher Dr. Benjamin Evans emphasized the importance of understanding this bacterium's evolutionary path to combat its spread effectively.
Dr. Evans stated, "We know that bacteria that cause infections in people can adapt to the antibiotics we use to treat them, rendering the antibiotics ineffective." This research provides crucial insights into how A. baumannii has become a formidable threat in healthcare settings.
Breakthroughs in Research Methodology
The research team utilized a unique collection of 226 bacterial samples dating back to the 1970s, which were grown in the lab and analyzed using advanced genome sequencing techniques. They merged these findings with over 1,000 modern genomes from six continents to create a comprehensive evolutionary tree.
By aligning genetic changes with specific sample dates and locations, the researchers identified the emergence and global spread of key resistance traits. This approach allowed them to reconstruct the pathogen's evolution, revealing how it transitioned to a dominant drug-resistant strain.
Key Findings and Implications for Healthcare
The study found that A. baumannii did not emerge suddenly as a superbug but gradually increased in prevalence over decades. By around 2005, it had become the leading lineage of A. baumannii worldwide. Notably, the acquisition of two significant genetic elements, including the oxa23 gene, marked a turning point in its resistance capabilities.
Moreover, the research identified at least four distinct groups of A. baumannii, each with its own evolutionary trajectory. The emergence of a new variant, referred to as group 4, raises concerns about even more adaptable strains potentially on the rise.
Dr. Evans concluded, "Understanding how antibiotic-resistant bacteria respond to changes in antibiotic use over time is essential for guiding policies on how we use antibiotics now and in the future." This research is critical for addressing the ongoing threat that A. baumannii poses to healthcare systems globally.
🤖 This article was rewritten by Feed and Figures' editorial AI from a report originally published by Phys.org. Facts and quotes are preserved from the original; the rewrite focuses on clarity and structure. For the unedited original, see the source link below.
